SW1573

Export PDF

Strain Information

Cell Line

SW1573

Cat. NO.

NM-FX04

Model Description

The SW 1573 line was established in 1977 by A. Leibovitz from an alveolar cell carcinoma.

Strain State

Validation of tumorigenic capacity completed

Validation Data

image.png

Fig1. Morphology of SW1573 cell line.

Ａimage.png

Ｂimage.png

Fig2. Analysis of Tumorigenesis in M-NSG mice（n=5）. SW1573 cells were subcutaneously inoculated in M-NSG mice. a Tumor volume was measured by time. b Body weight was simultaneously checked.

*Wild-type cell lines are not for sale, and only applied to construction of tumor bearing mice and in-vivo efficacy studies.

Related Strain(s)

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more